ASTRO: HRQOL Superior With SBRT for Intermediate-Risk Localized Prostate Cancer

FRIDAY, Oct. 3, 2025 (HealthDay News) -- For patients with intermediate-risk localized prostate cancer, stereotactic body radiation therapy (SBRT) yields favora